Kawamura M, Uozumi K, Maki T, Tauchi N, Takashima Y
Jpn J Antibiot. 1978 Jul;31(7):395-400.
PC-904 was administered to 3 pediatric patients with serious infections resistant clinically to other antibiotics (2 cases of sepsis and 1 case of pseudomonal pneumonia). Daily dosage was 100 approximately 150 mg/kg and intravenous infusions were carried out in 2 or 3 divided doses. This drug showed clinically and bacteriologically good response in these patients without any side effect, and was considered to be a useful drug or worthwhile to use in the treatment of the serious infectious diseases such as sepsis or pseudomonal infections.
PC - 904被给予3名临床上对其他抗生素耐药的严重感染儿科患者（2例败血症和1例铜绿假单胞菌肺炎）。每日剂量约为100至150mg/kg，分2或3次静脉输注。该药物在这些患者中显示出临床和细菌学上的良好反应，且无任何副作用，被认为是治疗败血症或铜绿假单胞菌感染等严重传染病的有用药物或值得使用的药物。
